Intermediate-dose prophylactic anticoagulation with low molecular weight heparin is safe after bioprosthetic artificial heart implantation

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

  • David M. Smadja
  • Peter Ivak
  • Yuri Pya
  • Christian Latremouille
  • Gustafsson, Finn
  • Jean Christian Roussel
  • Andre Vincentelli
  • Erwan Flecher
  • Piet Jansen
  • Ivan Netuka
OriginalsprogEngelsk
TidsskriftJournal of Heart and Lung Transplantation
Vol/bind41
Udgave nummer9
Sider (fra-til)1214-1217
Antal sider4
ISSN1053-2498
DOI
StatusUdgivet - 2022

Bibliografisk note

Funding Information:
The A-TAH CE Mark Study was sponsored by Carmat SA and this work was supported by Carmat SA.

ID: 322282083